teprotumumab

FDA Drug Profile — TEPEZZA

Drug Details

Generic Name
teprotumumab
Brand Names
TEPEZZA
Application Number
BLA761143
Sponsor
Horizon Therapeutics USA, Inc.
NDC Codes
1
Dosage Forms
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients
TEPROTUMUMAB

Indications and Usage

1 INDICATIONS AND USAGE TEPEZZA is indicated for the treatment of Thyroid Eye Disease regardless of Thyroid Eye Disease activity or duration. TEPEZZA is an insulin-like growth factor-1 receptor inhibitor indicated for the treatment of Thyroid Eye Disease ( 1 )